Omada Health beats on revenue in first earnings report since IPO

Group 1 - The company reported a 49% increase in revenue for Q2, reaching $61 million compared to $41.21 million a year earlier, exceeding analysts' expectations of $55.2 million [1][3] - The net loss for the quarter was $5.31 million, translating to a loss of 24 cents per share, an improvement from a net loss of $10.69 million or $1.40 loss per share in the same period last year [1][3] - CEO Sean Duffy highlighted the company's ability to capitalize on trends in cardiometabolic care and advancements in artificial intelligence as key factors in their performance [2]